ProCE Banner Series

Moderate to Severe Atopic Dermatitis Across the Lifespan: Strategies for NPs and PAs to Optimize Care at Every Age

Nurse practitioners (NPs) and physician associates (PAs) who manage atopic dermatitis lack familiarity with the latest information on biologic therapies. This case-based course covers the latest practice guidelines to prepare NPs and PAs for prescribing these therapies for their patients.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This education is intended for nurse practitioners and physician associates who are involved in the management of children and adults with moderate to severe atopic dermatitis.

All Events

Moderate to Severe Atopic Dermatitis Across the Lifespan: Strategies for NPs and PAs to Optimize Care at Every Age

Upcoming Events

June

09

2025

6:30 PM - 7:30 PM Mountain Time (MT)

Virtual

June

19

2025

8:00 PM - 9:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge, competence, and performance in the management of children and adults with moderate to severe atopic dermatitis. 

Target Audience
This activity is intended for nurse practitioners and physician associates who are involved in the management of children and adults with moderate to severe atopic dermatitis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement patient-reported outcomes into the diagnosis, severity assessment, and treatment decisions for children and adults with moderate to severe AD
  • Apply available evidence to patient selection for systemic therapies for moderate to severe AD
  • Develop patient-centered care strategies by involving patients in the long-term management of moderate to severe AD, considering quality of life and functional goals

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Practicing Clinicians Exchange (PCE)

Partners for Advancing Clinical Education (PACE) 2025
Practicing Clinicians Exchange

Supporters

This educational activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

Sanofi

Regeneron Pharmaceuticals

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191